D, M., MA, D., I, K., P, R., A, P., E, T., . . . MC, K. (2013). Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents. Hematological oncology, 31(2), 96. https://doi.org/10.1002/hon.2026
Chicago Style (17th ed.) CitationD, Maltezas, et al. "Re-evaluation of Prognostic Markers Including Staging, Serum Free Light Chains or Their Ratio and Serum Lactate Dehydrogenase in Multiple Myeloma Patients Receiving Novel Agents." Hematological Oncology 31, no. 2 (2013): 96. https://doi.org/10.1002/hon.2026.
MLA (9th ed.) CitationD, Maltezas, et al. "Re-evaluation of Prognostic Markers Including Staging, Serum Free Light Chains or Their Ratio and Serum Lactate Dehydrogenase in Multiple Myeloma Patients Receiving Novel Agents." Hematological Oncology, vol. 31, no. 2, 2013, p. 96, https://doi.org/10.1002/hon.2026.
